Local view for "http://wifo5-04.informatik.uni-mannheim.de/drugbank/resource/drugs/DB04468"
| Predicate | Value (sorted: default) |
|---|---|
| rdfs:label |
"Afimoxifene"
|
| rdf:type | |
| ns1:description |
"Afimoxifene (4-Hydroxytamoxifen, trade name TamoGel) is a new estrogen inhibitor under investigation for a variety of estrogen-dependent conditions, including cyclic breast pain and gynecomastia. TamoGel is formulated using Enhanced Hydroalcoholic Gel (EHG) Technology. This technology enables percutaneous delivery of drugs that cannot be delivered orally. It is being developed by Ascent Therapeutics."
|
| ns1:drugCategory | |
| owl:sameAs |
All properties reside in the graph file:///home/swish/src/ClioPatria/guidelines/drugbank_small.nt
The resource does not appear as an object